Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.

Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM.

J Clin Endocrinol Metab. 2009 Nov;94(11):4216-23. doi: 10.1210/jc.2009-1097. Epub 2009 Oct 6.

PMID:
19808848
[PubMed - indexed for MEDLINE]
2.

The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.

Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2003 May;58(5):601-11.

PMID:
12699442
[PubMed - indexed for MEDLINE]
3.

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.

Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS.

J Clin Endocrinol Metab. 2004 Apr;89(4):1613-7.

PMID:
15070920
[PubMed - indexed for MEDLINE]
4.

Mortality in patients with pituitary disease.

Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM.

Endocr Rev. 2010 Jun;31(3):301-42. doi: 10.1210/er.2009-0033. Epub 2010 Jan 19. Review.

PMID:
20086217
[PubMed - indexed for MEDLINE]
5.

Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.

Petersons CJ, Mangelsdorf BL, Thompson CH, Burt MG.

J Clin Endocrinol Metab. 2014 Jun;99(6):2269-76. doi: 10.1210/jc.2013-4305. Epub 2014 Feb 25.

PMID:
24606100
[PubMed - indexed for MEDLINE]
6.

Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.

Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.

Clin Endocrinol (Oxf). 2004 Jun;60(6):688-93.

PMID:
15163331
[PubMed - indexed for MEDLINE]
7.

Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.

DeVile CJ, Stanhope R.

Clin Endocrinol (Oxf). 1997 Jul;47(1):37-41.

PMID:
9302370
[PubMed - indexed for MEDLINE]
8.

Pituitary gland: predictors of acromegaly-associated mortality.

Ben-Shlomo A.

Nat Rev Endocrinol. 2010 Feb;6(2):67-9. doi: 10.1038/nrendo.2009.267.

PMID:
20098446
[PubMed - indexed for MEDLINE]
9.

Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study.

Bogazzi F, Colao A, Rossi G, Lombardi M, Urbani C, Sardella C, Iannelli A, Scattina I, Manetti L, Del Sarto S, Pivonello R, Grasso LF, Lupi I, Auriemma RS, Lombardi G, Martino E.

Eur J Endocrinol. 2013 Aug 28;169(3):367-76. doi: 10.1530/EJE-13-0166. Print 2013 Sep.

PMID:
23828855
[PubMed - indexed for MEDLINE]
Free Article
10.

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.

Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM.

Lancet. 2001 Feb 10;357(9254):425-31.

PMID:
11273062
[PubMed - indexed for MEDLINE]
11.

Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.

Peacey SR, Wright D, Aye M, Moisey R.

Clin Endocrinol (Oxf). 2012 Jul;77(1):94-8. doi: 10.1111/j.1365-2265.2011.04314.x.

PMID:
22151005
[PubMed - indexed for MEDLINE]
12.

A nationwide survey of mortality in acromegaly.

Kauppinen-Mäkelin R, Sane T, Reunanen A, Välimäki MJ, Niskanen L, Markkanen H, Löyttyniemi E, Ebeling T, Jaatinen P, Laine H, Nuutila P, Salmela P, Salmi J, Stenman UH, Viikari J, Voutilainen E.

J Clin Endocrinol Metab. 2005 Jul;90(7):4081-6. Epub 2005 May 10.

PMID:
15886256
[PubMed - indexed for MEDLINE]
13.

Ten years on: Safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice.

Gleeson HK, Walker BR, Seckl JR, Padfield PL.

J Clin Endocrinol Metab. 2003 May;88(5):2106-11.

PMID:
12727962
[PubMed - indexed for MEDLINE]
14.

Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).

Colao A, Vandeva S, Pivonello R, Grasso LF, Nachev E, Auriemma RS, Kalinov K, Zacharieva S.

Eur J Endocrinol. 2014 Aug;171(2):263-73. doi: 10.1530/EJE-13-1022. Epub 2014 May 30.

PMID:
24878680
[PubMed - indexed for MEDLINE]
15.

Long-term effects of megavoltage radiotherapy in acromegaly.

Lam KS, Wang C, Choi P, Ma JT, Yeung RT.

Aust N Z J Med. 1989 Jun;19(3):202-6.

PMID:
2549927
[PubMed - indexed for MEDLINE]
16.

Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.

Zueger T, Kirchner P, Herren C, Fischli S, Zwahlen M, Christ E, Stettler C.

J Clin Endocrinol Metab. 2012 Oct;97(10):E1938-42. doi: 10.1210/jc.2012-2432. Epub 2012 Aug 7.

PMID:
22872686
[PubMed - indexed for MEDLINE]
17.

Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.

Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, Thompson CJ, Agha A.

Clin Endocrinol (Oxf). 2011 Oct;75(4):505-13. doi: 10.1111/j.1365-2265.2011.04074.x.

PMID:
21521342
[PubMed - indexed for MEDLINE]
18.

Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.

Yap LB, Turner HE, Adams CB, Wass JA.

Clin Endocrinol (Oxf). 2002 Jan;56(1):25-31.

PMID:
11849243
[PubMed - indexed for MEDLINE]
19.

Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly.

Epaminonda P, Porretti S, Cappiello V, Beck-Peccoz P, Faglia G, Arosio M.

Clin Endocrinol (Oxf). 2001 Aug;55(2):183-9.

PMID:
11531924
[PubMed - indexed for MEDLINE]
20.

Increased cerebrovascular mortality in patients with hypopituitarism.

Bülow B, Hagmar L, Mikoczy Z, Nordström CH, Erfurth EM.

Clin Endocrinol (Oxf). 1997 Jan;46(1):75-81.

PMID:
9059561
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk